These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27261834)

  • 1. Dronedarone: Basic Pharmacology and Clinical Use.
    Tadros R; Nattel S; Andrade JG
    Card Electrophysiol Clin; 2016 Jun; 8(2):453-65. PubMed ID: 27261834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dronedarone: an overview.
    Kozlowski D; Budrejko S; Lip GY; Mikhailidis DP; Rysz J; Raczak G; Banach M
    Ann Med; 2012 Feb; 44(1):60-72. PubMed ID: 21745093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study.
    Pamukcu B; Lip GY
    Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dronedarone: current evidence for its safety and efficacy in the management of atrial fibrillation.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Drug Des Devel Ther; 2011 Jan; 5():27-39. PubMed ID: 21267357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: an emerging therapy for atrial fibrillation.
    Rosei EA; Salvetti M
    Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronedarone: a review of characteristics and clinical data.
    Baroletti S; Catella J; Ehle M; Cheng JW
    Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone--a new alternative for management of atrial fibrillation.
    Hundal M; Garg RK
    Recent Pat Cardiovasc Drug Discov; 2010 Jan; 5(1):47-53. PubMed ID: 20001929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dronedarone for the management of atrial fibrillation.
    Brenner R; Delacrétaz E
    Swiss Med Wkly; 2011; 141():w13158. PubMed ID: 21370206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dronedarone for atrial fibrillation therapy.
    Marzocchi M; Lombardi F
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drugs for atrial fibrillation: focus on dronedarone.
    Krishnamoorthy S; Lip GY
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):473-81. PubMed ID: 19419255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the investigational antiarrhythmic agent dronedarone.
    Tafreshi MJ; Rowles J
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):15-26. PubMed ID: 17495254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
    Singh BN; Connolly SJ; Crijns HJ; Roy D; Kowey PR; Capucci A; Radzik D; Aliot EM; Hohnloser SH;
    N Engl J Med; 2007 Sep; 357(10):987-99. PubMed ID: 17804843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug safety evaluation of dronedarone in atrial fibrillation.
    De Ferrari GM; Dusi V
    Expert Opin Drug Saf; 2012 Nov; 11(6):1023-45. PubMed ID: 22971242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.